Related Experiment Video
Updated: Jun 11, 2025

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
Point-of-Care Testing for Cardiovascular Disease: A Narrative Review
Xiaolong Liu1,2,3, Mengxiao He4, Rongbo Hu5
1School of Life and Environmental Science, Guilin University of Electronic Technology, Guilin, Guangxi, 541004, China.
Insights
Point-of-care testing (POCT) innovations are vital for managing cardiovascular disease. This review analyzes current POCT methods, highlighting their applications, effectiveness, and future potential for early diagnosis and treatment.
Area of Science:
- Biomedical Engineering
- Clinical Diagnostics
- Public Health
Background:
- Cardiovascular disease (CVD) presents a significant global health burden.
- Point-of-care testing (POCT) is essential for CVD prevention, early diagnosis, and management.
- A variety of POCT technologies exist, each with unique applications and performance characteristics.
Purpose of the Study:
- To provide a comprehensive analysis of current POCT technologies for cardiovascular disease.
- To assess the effectiveness and limitations of various POCT methods.
- To offer insights into future research and clinical applications of POCT in CVD.
Main Methods:
- Review of existing literature on POCT for cardiovascular disease.
- Analysis of conventional methods, paper-based microfluidics, microfluidic chips, electrochemical, ultrasonic, and smartphone-based detection technologies.
- Evaluation of performance across different detection scenarios.
Main Results:
- Diverse POCT technologies demonstrate varied applications and performance in cardiovascular disease detection.
- Conventional and advanced methods like microfluidics and electrochemical sensors show promise.
- Smartphone-based technologies offer potential for accessible, widespread use.
Conclusions:
- POCT technologies are critical for improving cardiovascular disease outcomes.
- Understanding the strengths and weaknesses of each POCT method is key for clinical implementation.
- Continued innovation in POCT will drive advancements in cardiovascular care.
Abstract:
Cardiovascular disease is a major global public health challenge. Point-of-- care testing (POCT) technologies are crucial for the prevention, early diagnosis, and treatment of cardiovascular conditions. Numerous POCT technologies for cardiovascular disease are currently available, which include but are not limited to conventional methods, paper-based microfluidic technology, microfluidic chip technology, electrochemical detection technology, ultrasonic detection technology, and smartphone-based detection technology. Each method has a broad range of applications and performs differently across various detection scenarios. This article offers a comprehensive analysis of current POCT technologies for cardiovascular disease, assessing their effectiveness, limitations, and future development directions. The aim is to provide insights and theoretical references for innovative research and clinical applications in POCT methods for cardiovascular disease.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Cardiovascular Drugs: Classification based on Therapeutic Indications
Pulse rhythm
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
Acute Coronary Syndrome III: Diagnostic studies
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...

